| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigations |
1 Imagerie du vivant, PET Centre, Centre d’Etude et de Recherche Multimodales et Pluridisciplinaires, Lyon, France
2 Centre Nationale de la Recherche Scientifique, Paris, France
3 Équipe d’Accueil 1880, Neurological Hospital, Lyon, France
4 Institut National de la Santé et de la Recherche Médicale, Paris, France
5 Institut Fédératif des Neurosciences de Lyon, Lyon, France
6 Université Claude Bernard de Lyon, Lyon, France
Neurotransmission imaging studies require normative data for the statistical assessment of neurophysiologic dysfunctions. 2'-Methoxyphenyl-(N-2'-pyridinyl)-p-18F-fluoro-benzamidoethylpiperazine (18F-MPPF) is a specific serotonin 5-HT1A antagonist PET tracer recently characterized, modeled, and used for clinical research to explore abnormalities in the serotoninergic system. Our study reports, to our knowledge, the first large normative imaging database of 18F-MPPF binding potential (BP) over aging, for both males and females. Methods: Fifty-three healthy volunteers (27 females, 26 males; age, 20–70 y) were selected to undergo structural MRI and single-injection 18F-MPPF multiframe dynamic PET. 18F-MPPF BP values were computed using a nonlinear modeling method with tissue reference. The statistical assessment of the effect of age and sex was performed both at the anatomic structure level, using regions of interest drawn manually on individual MR images, and at the voxel level, using normalized BP parametric images in different statistical parametric mapping designs. Results: A negative linear correlation between age and 18F-MPPF binding (3.6% decrease by decade) was found in females but not in males and involved most of the limbic and paralimbic regions; on the other hand, males in their 30s showed decreased binding in most cerebral regions. Conclusion: A comparison of males and females revealed higher BP values independent of age in females in the right hemisphere and a different evolution of BP over aging. These results confirm the necessity of a database for further statistical analysis in individuals or groups with pathology.
Key Words: PET • ligand • serotonin receptors • 5-HT1A • database
Related articles in JNM:
This article has been cited by other articles:
|
|
 |
|
  A. Lothe, A. Didelot, A. Hammers, N. Costes, M. Saoud, F. Gilliam, and P. Ryvlin Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study Brain, October 1, 2008; 131(10): 2765 - 2782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Didelot, P. Ryvlin, A. Lothe, I. Merlet, A. Hammers, and F. Mauguiere PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy Brain, October 1, 2008; 131(10): 2751 - 2764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hurley and K. H. Taber Imaging of Eating Disorders: Multiple Techniques to Demonstrate the Dynamic Brain J Neuropsychiatry Clin Neurosci, August 1, 2008; 20(3): iv - 260. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Truchot, S. N. Costes, L. Zimmer, B. Laurent, D. Le Bars, C. Thomas-Anterion, B. Croisile, B. Mercier, M. Hermier, A. Vighetto, et al. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment Neurology, September 4, 2007; 69(10): 1012 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Costes, L. Zimmer, A. Reilhac, F. Lavenne, P. Ryvlin, and D. Le Bars Test Retest Reproducibility of 18F-MPPF PET in Healthy Humans: A Reliability Study J. Nucl. Med., August 1, 2007; 48(8): 1279 - 1288. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
